Globus Medical, Inc.
GMED
$58.17
-$0.08-0.14%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,160.31% | 76.30% | 5,093.99% | -44.97% | -114.49% |
| Total Depreciation and Amortization | 19.39% | -4.12% | 79.06% | 251.80% | 205.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.26% | 38.30% | 265.31% | 880.45% | 551.78% |
| Change in Net Operating Assets | 122.48% | 160.06% | 2,288.07% | -141.16% | -102.38% |
| Cash from Operations | 238.44% | 100.95% | 303.40% | 54.90% | -1.74% |
| Capital Expenditure | -26.38% | 25.22% | -94.82% | -55.57% | -78.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 99.97% | -- | -375.17% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3,220.70% | -125.33% | -88.43% | -68.18% | -118.10% |
| Cash from Investing | 382.04% | -132.48% | 81.49% | -119.87% | -523.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 228.83% | 6,561.83% | 612.49% | 345.08% | -29.76% |
| Repurchase of Common Stock | -117.40% | 99.60% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.24% | -304.32% | -64.46% | -62.93% | -1,488.07% |
| Cash from Financing | -449.08% | 125.18% | 1,274.25% | 703.41% | -4,036.09% |
| Foreign Exchange rate Adjustments | 206.85% | -1,132.85% | 92.08% | 771.36% | -12,638.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -185.41% | -13.85% | 891.38% | -36.51% | -268.45% |